CLOs on the Move

Eurohypo AG

www.eurohypo.com

 
Eurohypo AG is a New York, NY-based company in the Financial Services sector.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Batterymarch Financial Management

Batterymarch Financial Management is one of the leading companies in the Financial Services sector.

Sf Investments

Sf Investments, Inc. is a Highland Park, IL-based company in the Financial Services sector.

Lazard Asset Management

Lazard Asset Management is known for its global perspective on investing and its experience with global, regional and domestic portfolios. We believe in fostering a culture of constant dialogue between teams. The resulting views bring us the unique, firsthand market insights that are the key to our long-term success. At Lazard Asset Management having an entrepreneurial spirit means that our teams are independent, but supported by a central infrastructure. This central infrastructure allows teams to focus on what they do best. With over $229.7 billion in assets under management (as of December 31, 2020). We have offices located throughout the world in Amsterdam, Brussels, Boston, Dubai, Dublin, Frankfurt, Geneva, Hamburg, Hong Kong, London, Madrid, Melbourne, Milan, Montreal, New York, Palo Alto, San Francisco, Seoul, Singapore, Sydney, Tokyo, Toronto and Zurich.

Abdiel Capital

Founded in 2006, Abdiel Capital Advisors, LP is a concentrated long-only value investment firm based in New York. Abdiel generally invests in publicly traded companies that are likely to gain market share over long time periods. We prefer businesses that have recurring revenue and that are managed by people with a large share of their net worth in the stock. Our ten largest investments frequently comprise more than 75% of invested capital.

Third Rock Ventures

Our team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed.